Cannabidiol (CBD) is a compound extracted from hemp or marijuana. The Agriculture Improvement Act of 2018 (Farm Bill) excluded hemp and its constituents from the definition of marijuana and removed it from the Controlled Substances Act (CSA). Hemp is a valuable agricultural commodity and contains only trace levels of tetrahydrocannabinol (THC), the intoxicating compound in marijuana. Hemp has been cultivated throughout human history for many purposes, including food, fiber, and oil. Modern science has demonstrated that, in addition to its value as a food and fiber, hemp extracts naturally contain CBD and that CBD may have its own health-promoting benefits. Now, by excluding hemp from the definition of marijuana, hemp with no more than 0.3 percent THC (and its constituents such as CBD) is no longer a controlled substance under the CSA.

CBD’s prior status as a Schedule I controlled substance presented significant barriers to clinical research. However, in the past few years, changes to state and federal laws have removed some of the obstacles to conducting research. Scientists and physicians have demonstrated that CBD may have multiple benefits throughout the body. Emerging research shows that CBD interacts with cellular receptors in physiological processes that influence sleep, mood, and appetite without intoxicating effects.

Research suggests that CBD can safely be used in dietary supplements. It has been established that CBD contains negligible amounts of THC, the psychoactive component of cannabis, and that it is non-psychoactive and does not cause a “high” in users. Further, CBD does not have the potential for abuse or addiction. The World Health Organization (WHO) Expert Committee on Drug Dependence recommended not scheduling CBD within the International Drug Control Conventions. WHO cited the fact that there are no case reports of CBD abuse or dependence; no public health problems have been associated with CBD use; CBD has been found to be generally well tolerated with a good safety profile; and that there is no evidence that CBD is liable to be abused.1 Furthermore, the U.S. Health and Human Services Department (HHS) conducted a scientific review on CBD and concluded that it does not present a significant risk to the public health. HHS found that there is no evidence for classic drug withdrawal, no evidence that CBD causes physical or psychic dependence and no potential for abuse under the CSA2.

The Farm Bill removed hemp-derived CBD from Schedule I of the CSA, which means it will not be regulated as a controlled substance by the Drug Enforcement Agency (DEA). However, the Farm Bill did not affect other agencies with jurisdiction over the substance. FDA explicitly retains jurisdiction to regulate the use of CBD in food, beverages, dietary supplements and other FDA-regulated products. FDA takes the position that CBD may not be sold in the U.S. due to provisions in the Food, Drug and Cosmetic Act (FDCA) related to the use of dietary supplement and food ingredients that have been previously studied as drug ingredients. If a substance has been authorized for investigation as a new drug, “substantial clinical investigations” have started, and the existence of these investigations has been made public before the substance was used in a food or supplement, then the ingredient in question falls outside the definition of a dietary supplement or a food3. According to FDA, there is evidence that a CBD ingredient used in a drug product met these criteria prior to CBD ingredients’ use in food or supplements.  These exclusionary provisions of the FDCA were designed to help protect drug companies’ investments in research and development, not because of any concerns that ingredients that are studied as drugs are inherently unsafe in dietary supplements. There are currently a number of ingredients that are marketed both as dietary supplements and drugs, with no concerns about their safety profile, such as fish oil products.

Yes. The FDCA allows the HHS Secretary to create a regulation permitting the use of an ingredient in food and dietary supplements, despite a determination that it was first subject to clinical drug investigations as described above. This alternative would allow FDA to clearly establish a legal pathway to market for CBD as a food and dietary supplement. FDA Commissioner Dr. Scott Gottlieb raised the possible use of this authority in a December 20, 2018 statement on CBD following the passage of the Farm Bill. Clearly, FDA is open to and exploring this pathway4.

Exploring a legal path to market for food, beverages and dietary supplements containing CBD is consistent with FDA’s strong public health goals. Recognizing CBD products as lawful foods, beverages or dietary supplements would allow the agency to impose a reasonable regulatory framework around the processing, manufacturing and marketing of CBD products not intended for use as drugs. It would also permit the agency to enforce existing regulations regarding registration of manufacturing facilities; observance of good manufacturing practice regulations; supply chain security; compliance with food additive and new dietary ingredient provisions for food and dietary supplements; and post-market surveillance of serious adverse events. If FDA fails to act, consumer interest in CBD will continue to grow along with a thriving but plainly unlawful array of CBD products. No one benefits from a “wild west” scenario in which companies willing to risk FDA enforcement distribute these products without appropriate FDA oversight and guidance.

CBD, one of the 104 different cannabinoids found in cannabis plants, is the abbreviation for cannabidiol and interacts with the body via its endocannabinoid system. While THC, which is closely related to CBD, is psychoactive and causes a so-called ‘high’, CBD does not. The body itself also produces cannabinoids using its so-called endocannabinoid system. This system is involved in many physical processes such as regulating appetite, energy, metabolism, and sleep. Furthermore, endocannabinoids also play a role in a variety of psychological processes. The marijuana plant contains over 60 substances, the two most important ones being CBD (cannabidiol) and THC (tetrahydrocannabinol). THC is a psychoactive substance that that makes users feel ‘high’ when consuming cannabis. CBD, however, does not have these effects, which is the reason why recreational users often choose THC oil rather than CBD oil. THC is banned in most countries. Since CBD oil contains less than 0,05% of THC, however, it is legal in most European countries and may be freely traded and used.

The marijuana plant contains over 60 substances, the two most important ones being CBD (cannabidiol) and THC (tetrahydrocannabinol). THC is a psychoactive substance that that makes users feel ‘high’ when consuming cannabis. CBD, however, does not have these effects, which is the reason why recreational users often choose THC oil rather than CBD oil. THC is banned in most countries. Since CBD oil contains less than 0,05% of THC, however, it is legal in most European countries and may be freely traded and used.

The difference between Pure and Raw (formerly known as “organic”) resides in the products’ different production methods. The Pure variety is 100% organically sourced, grown, and produced: its CBD is extracted using by means of heating, whereas the RAW variety’s extraction method utilizes CO2. Due to this difference in production methods, PURE 5% CBD oil actually contains 5% of pure CBD, whereas the RAW oil may also contain other cannabinoids such as CBDA, CBG, CBN, CBC, and CBV. As such, that particular variety may contain 3% CBD with the other 2% consisting of other cannabinoids. Pure versions actually contain 5% pure CBD, while the RAW version also contains other cannabinoids such as CBDA, CBG, CBN, CBC, and CBV. So the 5% can in that case, for example, contain 3% CBD and 2% consists of other cannabinoids. While some users prefer pure, unadulterated CBD, others might prefer a solution containing a variety of different compounds. The PURE variety often has a more pleasant taste than the RAW one.

Most of these tests only screen for THC. As such, it is highly unlikely that I the minimum percentage of 0,05% found in CBD oil will be detected by a test. We are not aware of any known cases of positive test results.

The CBD oil sold in the Netherlands may not contain more than 0,05% THC by law, which is a negligible amount. Regular usage of CBD will not influence one’s ability to drive and may therefore safely be used. There are also oils on the market with a much higher THC content: users consuming these products are not permitted to participate in traffic.

This is entirely optional. All brands that are offered on CBDsense.com can be kept at room temperature, and their packaging indicates they are best kept in cool, dark places such as cellars or cupboards. All products are perfectly suitable for refrigeration, however, and some users actually prefer chilled CBD oil.

The CBD is extracted either by means of CO2 (the Raw varieties) or by heating (the Pure versions). These processes all take places within hours of harvesting the plants to guarantee a fresh, pure, and reliable product. Our various CBD products are all produced using the thick CBD paste resulting from this laborious and time-consuming production process. Because it’s so labour-intensive, and plants only produce a relatively small amount of pure CBD, these products are not cheap.

Knowing which strength CBD formula you need is really simple to figure out! Firstly, the varying milligram amounts signify low (250-500mg), mid-range (1000mg), high (2500mg), and maximum (5000mg) CBD dose concentration. Each unique formula provides a higher dose of cannabidiol — the active ingredient in our products — per 1 mL dropper.

  • 250mg pocket size 15 mL formula 1.0mg per drop (16.7mg/1 mL dropper)
  • 500mg concentrated 30 mL formula 1.0mg per drop (16.7mg/1 mL dropper)
  • 1000mg ultra concentrated 30 mL formula 2.0mg per drop (33.3mg/1 mL dropper)
  • 2500mg super concentrated 30 mL formula 5.0mg per drop (83.3mg/1 mL dropper)
  • 5000mg hyper concentrated formula 10.0mg per drop (166.7mg/1 mL dropper)

Gradually increasing and moderating your CBD intake to find the most effective daily dose is called titration. This process ensures that you are taking the right amount of CBD, based on your individual response to the formula. Begin by taking ¼ mL to ½ mL CBD oil (measured using the included graduated dropper). Wait four to six hours between doses. Increase the number of drops per dose as needed until effects are apparent. CBD maintains an excellent safety profile that shows it is generally well-tolerated, even in very high doses. That means it’s safe to vary your daily CBD intake to find what feels right for you over time. Usage statistics show that most people take an average of about 1 mL CBD in their preferred strength daily. How much CBD you take may differ from that of others depending on your individual wellness concerns. Some CBD users, for example, only need to take CBD as needed while others take CBD two or more times daily for best results.

Clinical study shows that CBD is remarkably safe to take — even in very high doses — and side effects are extremely rare.Reported CBD side effects include appetite changes (decrease/increase) or somnolence. Side effects are typically mild and transient, lasting no more than four to six hours.

CBD is very safe to take on its own. In certain instances, CBD may interfere with the way the body metabolizes certain prescription medications in the liver. This interaction potentially reduces the effectiveness of these medications over time.Talk to your doctor before adding CBD to your wellness plan if you are concurrently taking any prescription medications. Your doctor may need to monitor your individual response to the combination of CBD with your prescribed drugs and adjust your dose accordingly.

Yes… but it might not pass customs! CBD oil is not yet legal in all countries; while some countries exist in a relative grey area, such as France, in some countries, including Australia and China, CBD oil is illegal and could cause you big problems (including fines or even jail time) if you bring it into the country.

Because CBD oil is not yet heavily regulated by the government, it’s easy for companies to sell products that contain little to no CBD… or that contain nasty little extras you’d rather avoid (like heavy metals or pesticides). To make sure that you’re opting for only the best CBD oil, choose products made with organic hemp. Organic hemp often comes from Europe, though recent changes in regulations have made it legal to grow organic hemp in the United States as well. Also be sure you’re opting for CBD oils extracted with CO2 rather than butane, and don’t be afraid to ask for lab tests from the company if they are not already prominently displayed on the company website: any company producing its CBD oil properly will be happy to provide this information, which indicates not only how much CBD is present in a given oil but also the presence of any pesticides or heavy metals. Many companies will even do batch testing, so you can see the results from the exact batch of CBD oil you have purchased.

Have questions? We have answers!

No Problem, fill the form to submit your question. You can also visit our 805-Cannabis Forum where you can find answers to your questions, get updates and much more.

    Marijuana News by 420 Intel | Wildfires Expected To Impact Hemp Crops | Published 8:00 a.m. PT Sept. 24, 2020

    Wildfires in California affect hemp farms

    The West Coast wildfires may finally be slackening a bit thanks to kinder winds, merciful rain, and the heroic efforts of firefighters from Canada to Mexico, but the fight is far from over for cannabis growers whose crops went up in smoke and cannabis companies who will be struggling to stay afloat due to the diminished supply. The one-two punch of Covid-19 and the historic fires that ravaged (and in some cases are still ravaging) huge swaths of the western states may prove to be more than some businesses can withstand despite some industry leaders stepping up to lend a hand.

      High winds, hurricanes, and these record-smashing fires are painting an even grimmer picture for 2020-21, particularly for states such as Oregon, one of the country’s top hemp-producing regions. Prior to the onset of the fires, Oregon farms were anticipating bumper crops. However, data from the Oregon Department of Agriculture, the National Interagency Fire Center, and Oregon’s Office of Emergency Management analyzed in a recent report by Hemp Benchmarks estimates that as of September 15, 17% of grow sites statewide were facing imminent danger from wildfires.  The latest report from Hemp Benchmarks said, “According to a September 11 update from the Oregon Department of Agriculture (ODA), 35% of the state’s 26,365 acres registered for outdoor hemp cultivation are located in the two aforementioned jurisdictions.” (Jackson and Josephine Counties, located in Oregon’s Southwestern Valleys)   Unfortunately, actual burning is not the only threat that the fires pose to the cannabis industry. Evacuations mean that plants cannot be tended, irrigated, and harvested and high winds can be just as deadly to plants as fire, as well as debris, not to mention the myriad risks to human safety.

    A reduction in lab availability and capacity will slow required testing turnaround while supply chain disruption in the face of increasing demand and the natural end of the cultivating season means fewer chances for growers to recoup their losses and replenish the shortfall.   But farmers, workers, and entrepreneurs need not face these challenges alone. San Diego-based Platinum Vape donated $5000 to the CalFire Benevolent Foundation, while Mondo, the brand known for its dissolving CBD powder, is giving away free jars of the stuff to firefighters, healthcare workers, and government workers. Henry’s Original in Mendocino, California is offering to store other grower’s licensed products as moving products to unlicensed areas, even in evacuation scenarios, is restricted. Given the fact that cannabis growers are ineligible for crop insurance and have far less access to bank loans, who better than the cannabis community itself to identify problems and extend solutions to help its own? With months of backbreaking recovery efforts and supply chain fluctuation ahead, one can only hope that this brand of intra-industry aid continues.